Vaiopoulos AG, Dalamaga M, Katsimbri P, Koumourtzis M, et al. Real-world data show high efficacy of IL23 inhibitors guselkumab and risankizumab in psoriatic arthritis and difficult-to-treat areas. Int J Dermatol 2023;62:1404-1413.
PMID: 37747093